Jaguar Animal Health (NASDAQ:JAGX) Share Price Crosses Below 50 Day Moving Average – Here’s Why

Posted by Paula Ricardo on Jul 24th, 2026

Jaguar Animal Health, Inc. (NASDAQ:JAGX – Get Free Report) shares crossed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $2.65 and traded as low as $0.97. Jaguar Animal Health shares last traded at $1.03, with a volume of 228,810 shares trading hands.

Wall Street Analysts Forecast Growth

JAGX has been the topic of a number of research analyst reports. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Jaguar Animal Health in a report on Friday, July 17th. Wall Street Zen raised Jaguar Animal Health from a “sell” rating to a “hold” rating in a report on Saturday, May 23rd. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Jaguar Animal Health presently has an average rating of “Sell”.

View Our Latest Stock Analysis on JAGX

Jaguar Animal Health Trading Down 22.6%

The company has a market capitalization of $618,000.00, a price-to-earnings ratio of -0.00 and a beta of -0.11. The business’s 50 day moving average price is $2.65 and its two-hundred day moving average price is $13.47.

Jaguar Animal Health (NASDAQ:JAGX – Get Free Report) last released its quarterly earnings data on Wednesday, May 20th. The biotechnology company reported ($13.60) earnings per share for the quarter, beating the consensus estimate of ($149.10) by $135.50. The firm had revenue of $20.27 million for the quarter, compared to analyst estimates of $4.21 million.

Jaguar Animal Health Company Profile

(Get Free Report)

Jaguar Animal Health, Inc is a biopharmaceutical company focused on the development and commercialization of novel therapeutics for the gastrointestinal health of food-producing animals, with an emphasis on swine and poultry. The company’s research and development efforts target common enteric disorders such as post-weaning diarrhea in pigs and clostridial overgrowth in broiler chickens, aiming to provide effective alternatives to traditional antibiotic treatments.

Jaguar Animal Health was formed in early 2019 through the acquisition of the animal health business of Aratana Therapeutics by Actinium Animal Health, followed by a corporate rebranding.